Solid Biosciences participates in Guggenheim 3rd Annual Healthcare Innovation Conference

SLDB•2026-11-05

Solid Biosciences management will hold one-on-one investor meetings at Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston on Nov. 9, 2026.

1. Investor meetings

Solid Biosciences management will hold one-on-one investor meetings at the conference in Boston on Nov. 9, 2026.

Solid Biosciences participates in Guggenheim 3rd Annual Healthcare Innovation Conference

1. Investor meetings

Related News

Intellia Therapeutics Q3 net loss widens 26% to $127.49 million

Cenovus Energy: Raymond James raises target price to C$53 from C$51

Acorn Energy Q3 revenue rises on hardware sales, Gen-Tracker acquisition

Annovis Bio prices $21 million public offering

TransUnion: Lenders expand credit access for below-prime borrowers